The Case | Subcutaneous abdominal calcified nodules and severe hyperphosphatemia

Kidney Int. 2016 May;89(5):1171-1172. doi: 10.1016/j.kint.2015.10.017.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abdomen
  • Adult
  • Anticoagulants / adverse effects*
  • Biopsy
  • Calcinosis / chemically induced*
  • Calcinosis / diagnosis
  • Chelating Agents / therapeutic use
  • Drug Substitution
  • Enoxaparin / therapeutic use
  • Female
  • Humans
  • Hyperphosphatemia / chemically induced*
  • Hyperphosphatemia / diagnosis
  • Hyperphosphatemia / drug therapy
  • Nadroparin / adverse effects*
  • Risk Factors
  • Sevelamer / therapeutic use
  • Severity of Illness Index
  • Skin / drug effects*
  • Skin / pathology
  • Skin Diseases / chemically induced*
  • Skin Diseases / diagnosis
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Anticoagulants
  • Chelating Agents
  • Enoxaparin
  • Nadroparin
  • Sevelamer